Binghong Capital
Binghong Capital is a venture capital firm based in Beijing, China, specializing in investments in various sectors, with a notable focus on biotechnology. The firm manages the Binghong Bio-Tech Venture Fund, which was established in 2013 and aims to support innovative biotech companies within China. By leveraging its expertise and network, Binghong Capital seeks to identify and nurture promising startups that contribute to advancements in the biotechnology field.
3 past transactions
Keyto
Series B in 2021
Keyto specializes in the production of key electrical and mechanical components for microfluid system controls.
Sanbo Brain Hospital
Series B in 2020
Beijing Sanbo Brain Hospital Co., Ltd. is a private hospital in China that specializes in neurological care. Established in 2004, the hospital offers a wide range of services, including neurosurgery, neurology, anesthesiology, and pain management. It is equipped with advanced facilities such as ICU, imaging, pathology, cerebrovascular medicine, neuro-ophthalmology, neuro electrophysiology, magnetoencephalography rooms, and neuropsychology services. Sanbo Brain Hospital operates a network of six facilities located in Beijing, Chongqing, Kunming, Fuzhou, and Jinan, providing comprehensive care for patients with neurological conditions.
Zhongnong Ying Tailin Prefecture
Venture Round in 2018
Zhongnong Ying Tailin Prefecture is a developer of antibacterial peptide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.